Table 1.
Experimental group/ Timepoint | Morphometric Parameters | |||
---|---|---|---|---|
LVESD (mm) | LVEDD (mm) | LVESV (μl) | LVEDV (μl) | |
Day 0 | ||||
Vehicle (n = 3) | 1.75 ± 0.32 | 3.18 ± 0.36 | 9.46 ± 4.61 | 40.89 ± 11.65 |
MBwt + MBmdx (n = 3) | 1.76 ± 0.05 | 2.96 ± 0.03 | 10.83 ± 0.79 | 31.50 ± 1.41 |
MBwt + MSCmdx (n = 3) | 1.71 ± 0.17 | 2.65 ± 0.40 | 10.92 ± 0.99 | 31.51 ± 2.94 |
MBwt/MBmdx (n = 4) | 2.02 ± 0.57 | 3.25 ± 0.61 | 14.52 ± 10.5 | 44.35 ± 19.28 |
MBwt/MSCmdx (n = 3) | 0.78 ± 0.73 | 1.88 ± 1.06 | 2.51 ± 3.84 | 15.27 ± 18.09 |
Day 30 | ||||
Vehicle (n = 3) | 1.01 ± 0.59 | 2.33 ± 0.14 | 3.68 ± 3.48 | 18.81 ± 2.86 |
MBwt + MBmdx (n = 3) | 1.71 ± 0.13 | 2.55 ± 0.15 | 9.31 ± 1.03 | 24.51 ± 0.22 |
MBwt + MSCmdx (n = 3) | 1.86 ± 0.14† | 2.77 ± 0.16† | 10.12 ± 1.12 | 26.64 ± 0.24 |
MBwt/MBmdx(n = 4) | 2.40 ± 0.49‡ | 3.28 ± 0.31†‡ | 21.28 ± 11.43‡ | 44.01 ± 10.41‡ |
MBwt/MSCmdx (n = 3) | 1.48 ± 0.82‡ | 2.00 ± 0.93 | 9.14 ± 8.30 | 23.90 ± 19.21‡ |
Day 90 | ||||
Vehicle (n = 3) | 2.49 ± 0.52 | 3.29 ± 0.60 | 23.82 ± 11.48 | 46.10 ± 19.42 |
MBwt + MBmdx (n = 3) | 1.63 ± 0.30 | 2.60 ± 0.31 | 9.09 ± 4.49 | 28.75 ± 8.72 |
MBwt + MSCmdx (n = 3) | 1.79 ± 0.33 | 2.86 ± 0.34 | 9.99 ± 4.93 | 31.59 ± 9.58 |
MBwt/MBmdx (n = 4) | 2.03 ± 0.26 | 2.91 ± 0.29 | 13.62 ± 4.42 | 32.85 ± 8.20 |
MBwt/MSCmdx (n = 3) | 1.76 ± 0.05 | 2.89 ± 0.32 | 9.16 ± 0.66 | 32.61 ± 8.62 |
LVESD = left ventricular end systolic diameter, LVEDD = left ventricular end diastolic diameter, LVESV = left ventricular end systolic volume; LVEDV = left ventricular end diastolic volume; All values expressed as mean ± standard error; † Significant increase (p < 0.05) compared to vehicle group; ‡ Significant increase (p < 0.05) compared to corresponding non-fused cell group; †‡ Significant increase (p < 0.05) compared to vehicle and corresponding non-fused cell group